U.S. FDA panel to weigh Merck's COVID-19 antiviral drug – Reuters

U.S. FDA panel to consider Merck’s COVID-19 antiviral medicine – Reuters

A panel of professional advisors to the U.S. Food and also Drug Administration will certainly elect in the future Tuesday on whether to suggest consent of Merck & Carbon monoxide’s (MRK.N) antiviral tablet to deal with COVID-19.

Find out more …